Effect of COMT gene polymorphism on post-thoracotomy pain and analgesic requirements in patients receiving multimodal pre-emptive analgesia with pregabalin versus naproxen: A randomized clinical trial.
- 1Department of Anaesthesiology, UPUMS, Etawah, Uttar Pradesh, India.
- 2Department of Anaesthesiology, King George Medical University, Uttar Pradesh, India.
- 3Department of Anaesthesiology, Kalyan Singh Cancer Institute, Lucknow, Uttar Pradesh, India.
Abstract
Objective
To evaluate the association between catechol-O-methyltransferase (COMT) gene polymorphism and postoperative pain intensity and rescue analgesic requirements in thoracotomy patients receiving pre-emptive pregabalin versus naproxen.Methods
In this prospective randomized trial, 40 ASA I-II adults undergoing elective thoracotomy were randomized to pre-emptive oral pregabalin (2.5 mg/kg, n = 20) or naproxen (7 mg/kg, n = 20). All received standardized thoracic epidural and general anesthesia. COMT rs4633 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Postoperative numerical rating scale (NRS) pain scores and 24-hour rescue analgesia requirements were recorded.Results
The distribution of COMT genotypes was similar between groups (P = 0.74). Mean NRS scores were lower in Group I compared to Group II at 2 hours (3.6 ± 1.1 vs 4.0 ± 1.2), 6 hours (3.1 ± 1.0 vs 3.5 ± 1.1), 12 hours (2.7 ± 0.9 vs 3.0 ± 1.0), and 24 hours (2.5 ± 0.9 vs 2.8 ± 1.0), with no statistically significant difference (P > 0.05). At 24 hours, CT genotype patients showed higher pain scores than CC and TT genotypes in both groups (Group I: 2.9 ± 1.0; Group II: 3.1 ± 1.1). Rescue analgesia was required in 30% of Group I and 45% of Group II patients. Time to first rescue analgesia was longer in Group I (8.6 ± 3.2 h vs 7.4 ± 3.1 h), with fewer rescue doses [median 0 (IQR 0-1) vs 1 (IQR 0-2)].Conclusion
Despite non-significant results, CT genotype showed higher pain and analgesic needs, while pregabalin demonstrated a clinically favorable trend over naproxen.
Related
- Efficacy of Pregabalin versus Cinnarizine in Preventive Treatment of Children with Migraine Headache: A Randomized Double-Blind Clinical Trial Study
- Eltrombopag during induction chemotherapy in older patients with newly diagnosed acute myeloid leukemia is safe and reduces platelet transfusion requirements: The EPAG-2015 French Innovative Leukemia Organization phase 2 randomized trial.
- Age-stratified signals and early onset of adverse events with pregabalin: a disproportionality analysis of the FDA adverse event reporting system
- Left thoracotomy for redo left ventricular pseudoaneurysm repair after ventricular septal rupture surgery
- PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial
BibTeX
@article{das2026effect,
title = {{Effect of COMT gene polymorphism on post-thoracotomy pain and analgesic requirements in patients receiving multimodal pre-emptive analgesia with pregabalin versus naproxen: A randomized clinical trial.}},
author = {Prajjal Das and Rajni Gupta and Vaishali Singh},
journal = {Saudi journal of anaesthesia},
year = {2026},
month = oct,
doi = {10.4103/sja.sja_444_26},
url = {https://europepmc.org/article/MED/42960024},
note = {CC BY-NC-SA},
}
RIS
TY - JOUR
TI - Effect of COMT gene polymorphism on post-thoracotomy pain and analgesic requirements in patients receiving multimodal pre-emptive analgesia with pregabalin versus naproxen: A randomized clinical trial.
AU - Prajjal Das
AU - Rajni Gupta
AU - Vaishali Singh
PY - 2026
DA - 2026/10/01
JO - Saudi journal of anaesthesia
DO - 10.4103/sja.sja_444_26
UR - https://europepmc.org/article/MED/42960024
AB - Objective To evaluate the association between catechol-O-methyltransferase (COMT) gene polymorphism and postoperative pain intensity and rescue analgesic requirements in thoracotomy patients receiving pre-emptive pregabalin versus naproxen.Methods In this prospective randomized trial, 40 ASA I-II adults undergoing elective thoracotomy were randomized to pre-emptive oral pregabalin (2.5 mg/kg, n = 20) or naproxen (7 mg/kg, n = 20). All received standardized thoracic epidural and general anesthesia. COMT rs4633 genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Postoperative numerical rating scale (NRS) pain scores and 24-hour rescue analgesia requirements were recorded.Results The distribution of COMT genotypes was similar between groups (P = 0.74). Mean NRS scores were lower in Group I compared to Group II at 2 hours (3.6 ± 1.1 vs 4.0 ± 1.2), 6 hours (3.1 ± 1.0 vs 3.5 ± 1.1), 12 hours (2.7 ± 0.9 vs 3.0 ± 1.0), and 24 hours (2.5 ± 0.9 vs 2.8 ± 1.0), with no statistically significant difference (P > 0.05). At 24 hours, CT genotype patients showed higher pain scores than CC and TT genotypes in both groups (Group I: 2.9 ± 1.0; Group II: 3.1 ± 1.1). Rescue analgesia was required in 30% of Group I and 45% of Group II patients. Time to first rescue analgesia was longer in Group I (8.6 ± 3.2 h vs 7.4 ± 3.1 h), with fewer rescue doses [median 0 (IQR 0-1) vs 1 (IQR 0-2)].Conclusion Despite non-significant results, CT genotype showed higher pain and analgesic needs, while pregabalin demonstrated a clinically favorable trend over naproxen.
SN - 1658-354X
SN - 0975-3125
ER -